A SECRET WEAPON FOR WHO MAKES THE DIABETES DRUG COPYRIGHT

Novo Nordisk's pricing methods within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, stating the stark distinction among U.S. selling prices and people in Europe and copyright.In October 2024, Novo Nordisk printed a review on scientific journal Character a few novel glucose-del